Original Articles

The impact of glomerular filtration rate on short-term outcome in elderly patients with heart failure with preserved ejection fraction

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 28 December 2024
Accepted: 12 May 2025
Published: 1 July 2025
593
Views
552
Downloads
135
HTML

Authors

Heart failure with preserved ejection fraction is a frequent condition among the elderly. The prevalence of chronic kidney disease is also very high, accounting for 5-10% of the population. The aim of this study was to investigate whether the decrease in renal function, assessed by estimated glomerular filtration rate (eGFR), was an independent predictor of adverse events such as death and new hospitalizations in elderly patients hospitalized with heart failure with preserved ejection fraction. This study included hospitalized patients diagnosed with heart failure with preserved ejection fraction. Renal function was estimated by calculating glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration formula. Patients were stratified into two cohorts using the median eGFR value of 45.45 mL/min/1.73 m2 as the cutoff. During a 3-month follow-up, a total of 30 events were recorded. Multivariate logistic analysis adjusted for confounding factors such as age, gender, anemia, and therapy revealed that eGFR was an independent predictive factor in various models: odds ratio (OR): 0.96, 95% confidence interval (CI) 0.93-0.99, p=0.016; OR: 0.95, 95% CI 0.93-0.98, p=0.003. GFR is an independent predictive factor of short-term events in a population of elderly patients with heart failure with preserved ejection fraction.

Downloads

Download data is not yet available.
Emmons-Bell S, Johnson C, Roth G. Prevalence, incidence and survival of heart failure: a systematic review. Heart 2022;108:1351-60. DOI: https://doi.org/10.1136/heartjnl-2021-320131
Rashed A, Wasef M, Kalra PR. The 2023 ESC heart failure guideline update and its implications for clinical practice. Br J Cardiol 2024;31:023.
Ferrara N, Komici K, Corbi G, et al. Beta-adrenergic receptor responsiveness in aging heart and clinical implications. Front Physiol 2014;4:396. DOI: https://doi.org/10.3389/fphys.2013.00396
Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014;63:713-35. DOI: https://doi.org/10.1053/j.ajkd.2014.01.416
Charles C, Ferris AH. Chronic kidney disease. Prim Care 2020;47:585-95. DOI: https://doi.org/10.1016/j.pop.2020.08.001
Thind GS, Loehrke M, Wilt JL. Acute cardiorenal syndrome: mechanisms and clinical implications. Cleve Clin J Med 2018;85:231-9. DOI: https://doi.org/10.3949/ccjm.85a.17019
Kousa O, Mullane R, Aboeata A. Cardiorenal syndrome. Treasure Island, FL, USA: StatPearls Publishing; 2025.
Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006;47:1987-96. DOI: https://doi.org/10.1016/j.jacc.2005.11.084
Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006;113:671-8. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.580506
Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol 2007;165:710-8. DOI: https://doi.org/10.1093/aje/kwk052
McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004;109:1004-9. DOI: https://doi.org/10.1161/01.CIR.0000116764.53225.A9
Bibbins-Domingo K, Lin F, Vittinghoff E, et al. Renal insufficiency as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol 2004;44:1593-600. DOI: https://doi.org/10.1016/j.jacc.2004.07.040
Okuno K, Naito Y, Asakura M, et al. Anemia has an impact on prognosis in heart failure with preserved ejection fraction with mild chronic kidney disease. Int J Cardiol Heart Vasc 2021;34:100796. DOI: https://doi.org/10.1016/j.ijcha.2021.100796
Mahon NG, Blackstone EH, Francis GS, et al. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 2002;40:1106-13. DOI: https://doi.org/10.1016/S0735-1097(02)02125-3
McClellan WM, Flanders WD, Langston RD, et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002;13:1928-36. DOI: https://doi.org/10.1097/01.ASN.0000018409.45834.FA
Mezhonov EM, Reitblat OM, Vyalkina YA, et al. Chronic kidney disease and chronic heart failure: impact on prognosis and choice of pathogenetic therapy. Ter Arkh. 2024;96:666-74. DOI: https://doi.org/10.26442/00403660.2024.07.202781
Yano M, Nishino M, Ukita K, et al. Clinical impact of blood urea nitrogen, regardless of renal function, in heart failure with preserved ejection fraction. Int J Cardiol 2022;363:94-101. DOI: https://doi.org/10.1016/j.ijcard.2022.06.061
Chen Z, Lin Q, Li J, et al. Estimated glomerular filtration rate is associated with an increased risk of death in heart failure patients with preserved ejection fraction. Front Cardiovasc Med 2021;8:643358. DOI: https://doi.org/10.3389/fcvm.2021.643358
McCullough PA. Why is chronic kidney disease the “spoiler” for cardiovascular outcomes? J Am Coll Cardiol 2003;41:725-8. DOI: https://doi.org/10.1016/S0735-1097(02)02955-8
Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 2008;52:818-27. DOI: https://doi.org/10.1016/j.jacc.2008.04.061
Okuno K, Naito Y, Asakura M, et al. Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry. Heart Vessels 2019;34:1168-77. DOI: https://doi.org/10.1007/s00380-019-01349-6
Lee DS, Gona P, Vasan RS, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 2009;119:3070-7. DOI: https://doi.org/10.1161/CIRCULATIONAHA.108.815944
Tribouilloy C, Rusinaru D, Mahjoub H, et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 2008;29:339-47. DOI: https://doi.org/10.1093/eurheartj/ehm554

How to Cite



The impact of glomerular filtration rate on short-term outcome in elderly patients with heart failure with preserved ejection fraction. (2025). Geriatric Care, 11(2). https://doi.org/10.4081/gc.2025.13542